The NBA’s Audacious Plan for New Teams and Even More Money—Across the Atlantic Ocean
America’s premier basketball league wants to expand operations to Europe. It sets up a potential showdown with the existing EuroLeague.
- The NBA is planning to start a league in Europe to tap into new revenue streams, given basketball’s popularity there.
- The NBA aims to collaborate with the EuroLeague but believes the existing framework underutilizes the business opportunity.
- The new league may allow sovereign-wealth funds to take controlling stakes in franchises, with fees between $500M-$1B.
In recent years, European basketball has conquered the NBA. Top players from Greece and Serbia have gobbled up MVP awards and championships. And when the Los Angeles Lakers made the most stunning trade in league history this year, it was for a star from Slovenia.
Now, the NBA is aiming to conquer Europe. Commissioner Adam Silver is planning to start a league on the other side of the Atlantic Ocean—all in a bid to open up new revenue streams for America’s most globally popular league.
“In virtually every country or territory around the world, basketball is the No. 1 or No. 2 sport,” said deputy commissioner Mark Tatum. “By definition, our biggest growth opportunities are outside the United States.”
But the NBA isn’t heading into uncharted territory. Europe already has a slew of domestic leagues and the well-established EuroLeague, which has crowned the continent’s basketball champions—and exported future NBA superstars such as Luka Doncic—for the past 25 years.
Ahead of this trans-Atlantic showdown, EuroLeague CEO Paulius Motiejunas has said that his league would prefer to cooperate with the NBA on a possible joint venture. If the NBA insists on starting a second operation, however, then the EuroLeague is prepared to dig in for a fight, Motiejunas said.
The NBA has expressed openness to working with the EuroLeague but believes the existing framework hasn’t made the most of a substantial business opportunity.
“Where we are in terms of the level of interest in basketball in Europe is not commensurate with the commercial activities,” Silver said last year.
In recent days, Silver and Tatum toured Europe, meeting with, U.K. Prime Minister Keir Starmer, representatives of Abu Dhabi’s department of culture and tourism, and Spanish sports powerhouse Real Madrid, where Doncic once played. To prove that it is serious about moving quickly, the NBA has also retained JPMorgan and the Raine Group to advise on league structures and secure investment.
The proposed league, organized by the NBA and the International Basketball Federation, would include 14 to 16 teams, including a combination of existing basketball powers and new franchises in major European cities. It would launch in the next two to three years, pending approval from FIBA and the NBA’s Board of Governors.
Crucially, the European project might also open up a potential for the NBA to do business with a new type of investor: uber-wealthy foreign states. Whereas sovereign-wealth funds are currently permitted to be only minority partners in the NBA, they could be allowed to take on controlling stakes of franchises in the European venture. Franchise fees will be between $500 million and $1 billion.
“Ownership rules haven’t been finalized,” Tatum said. “But we’re certainly contemplating potential primary ownership by sovereign-wealth funds.”
Those groups have already reshaped European soccer over the past two decades, helping push former also-ran clubs to unprecedented glory. Paris Saint-Germain, which won the Champions League for the first time in May, is owned by Qatar Sports Investments, for instance.
The San Antonio Spurs and Indiana Pacers played two games in Paris last season. Photo: stephanie lecocq/Reuters
But no matter who ends up owning the European franchises, the NBA expects the teams to be more profitable than what’s currently in place. Rabid supporters pour into arenas, but many of Europe’s largest cities don’t yet have permanent teams in the top tier of international competition—and many of the best teams, such as Real Madrid and Barcelona, are run as appendages to soccer behemoths.
Motiejunas, who said that two-thirds of EuroLeague teams lose money, said the way to boost revenue was for the EuroLeague and the NBA to join forces. But he found the asking price for new franchises ambitious.
“Football is the number one sport in Europe—[even] Premier League clubs don’t sell for this much,” Motiejunas said, referencing soccer teams in England’s top division.
The NBA envisions new franchises in markets like London, Paris and Rome. But historic attempts to meddle with the infrastructure of European sports haven’t always gone smoothly. Soccer’s proposed European Super League—a breakaway organization of a dozen wealthy teams—was met with widespread uproar in 2021 and folded in just 48 hours.
Motiejunas also warned that building a fan base in European cities is not as simple as designing a new logo.
“Fathers and grandfathers hand down jerseys of the team you support,” he said. “It would be really, really difficult to change their minds.”
Though the NBA anticipates some hurt feelings from clubs and fan bases not given permanent spots, it plans to allow for merit-based qualification for open slots in the league—a distinction from the opaque qualification systems for the existing EuroLeague.
“We want to bring the entire basketball ecosystem together in Europe,” Tatum said, “and we think that this approach is the best way to do that.”
Research Calls I
-
Upgrades
- America Movil (AMX) upgraded to Neutral from Underweight at JPMorgan, tgt $21
- Construction Partners (ROAD) upgraded to Outperform from Neutral at Robert W. Baird; tgt $122
- Cushman & Wakefield (CWK) upgraded to Buy from Sell at Goldman, tgt $17.50
- Diageo plc (DEO) upgraded to Neutral from Sell at Goldman
- Elf Beauty (ELF) upgraded to Buy from Hold at Deutsche Bank, tgt $121
- Fortinet (FTNT) upgraded to Buy from Hold at DZ Bank, tgt $85
- Gilead (GILD) upgraded to Buy from Hold at Truist, tgt $127
- GoDaddy (GDDY) upgraded to Overweight from Neutral at Piper Sandler, tgt $182
- Holley (HLLY) upgraded to Buy from Hold at Benchmark, tgt $4
- Instacart (CART) upgraded to Buy from Hold at The Benchmark Company, tgt $67
- LegalZoom (LZ) upgraded to Buy from Underperform at BofA Securities, tgt $12
- Monster Beverage (MNST) upgraded to Overweight from Neutral at Piper Sandler, tgt $74
- Novartis (NVS) upgraded to Equal Weight from Underweight at Morgan Stanley, tgt $123
- Peloton (PTON) upgraded to Buy from Neutral at Goldman, tgt $11.50
- Sanofi (SNY) upgraded to Overweight from Neutral at JP Morgan
- Viavi (VIAV) upgraded to Positive from Neutral at Susquehanna, tgt $15
- America Movil (AMX) upgraded to Neutral from Underweight at JPMorgan, tgt $21
-
Downgrades
- Atmos Energy (ATO) downgraded to Neutral from Buy at Ladenburg, tgt $163
- Avita Medical (RCEL) downgraded to Sell from Neutral at BTIG Research, tgt $3
- Coincheck (CNCK) downgraded to Neutral from Overweight at Cantor Fitzgerald, tgt $6
- Cogent (CCOI) downgraded to Sector Perform from Outperform at RBC Capital, tgt $40
- Crocs (CROX) downgraded to Hold from Buy at Williams Trading, tgt $80
- Crocs (CROX) downgraded to Hold from Buy at Stifel, tgt $85
- Crocs (CROX) downgraded to Equal Weight from Overweight at Barclays, tgt $81
- Flutter Entertainment (FLUT) downgraded to Hold from Add at Peel Hunt
- Haemonetics (HAE) downgraded to Neutral from Overweight at JP Morgan; tgt $62
- Health Catalyst (HCAT) downgraded to Neutral from Overweight at Cantor Fitzgerald; tgt $4
- Installed Building Products (IBP) downgraded to Hold from Buy at Loop Capital, tgt $255
- Primo Brands (PRMB) downgraded to Hold from Buy at Deutsche Bank, tgt $26
- Roche (RHHBY) downgraded to Underweight from Equal Weight at Morgan Stanley, tgt $39
- Rockwell Automation (ROK) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $345
- Televisa (TV) downgraded to Neutral from Buy at Goldman, tgt $2.60
- Telefonica Brasil (VIV) downgraded to Underweight from Neutral at JPMorgan
- Trade Desk (TTD) downgraded to Neutral from Buy at Citigroup, tgt $65
- Trade Desk (TTD) downgraded to Neutral from Outperform at Wedbush, tgt $68
- Trade Desk (TTD) downgraded to Neutral from Buy at BofA Securities, tgt $55
- Univ Elec (UEIC) downgraded to Neutral from Buy at Rosenblatt; tgt $8
- Vtex (VTEX) downgraded to Neutral from Outperform at Bradesco BBI, tgt $6
- Vtex (VTEX) downgraded to Neutral from Overweight at JPMorgan, tgt $6
- Atmos Energy (ATO) downgraded to Neutral from Buy at Ladenburg, tgt $163
-
Others
- Appian (APPN) resumed with a Neutral at DA Davidson; tgt $30
- James Hardie (JHX) initiated with a Buy at Jefferies; tgt $34
- PDF Solutions (PDFS) resumed with a Neutral at DA Davidson; tgt $24
Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- TTD -30.8% (also names new CFO), IOVA -28%, SG -24.7%, VTEX -22.3%, SEZL -19.2%, XPOF -18.2%, UAA -15.4%, TWLO -13.5%, PINS -11.8%, TECX -9.6%, MTW -8.2%, GRND -8.1%, FNKO -7.9% (also files for $100 mln mixed shelf; also files for offering by selling shareholders), GT -7.9%, BLND -7.6%, MCHP -7.6%, SLVM -7.1%, AMN -6.6%, LAMR -6.2%, EVH -5.6%, NRDS -5.1%, SERV -5.1%, GTN -5.1%, ESE -3.9%, RXST -3.6%, GDDY -3.5%, ARWR -3.4%, RXT -3.1%, FLUT -2.7%, DBX -2.6%, BHF -2.3%, CHYM -2.3%, ETNB -2.2%, TXRH -2.2%, YELP -2%, AGO -2%, CENX -1.9%, CPK -1.9%, BTG -1.8%, WYNN -1.6%, ICUI -1.5%, PTCT -1.2%, KTOS -1.1%, PBR -1%
Other news:
- HCAT -18.7% (CEO stepping down)
- AVDL -11.9% (files mixed securities shelf offering)
- FNKO -7.7% (files for $100 mln mixed shelf; also files for offering by selling shareholders)
- CTRI -7.2% (prices secondary offering of 15.0 mln shares of common stock by Southwest Gas Holdings (SWX) at $19.50 per share)
- VVX -6.2% (announces the sale of 2.0 million shares of its common stock on an underwritten basis by Vertex Aerospace Holdco)
- HRZN -4.6% (MRCC and HRZN to merge)
- CTMX -2.9% (files for $250 mln mixed securities shelf offering)
- RDW -1.1% (stock offering by selling shareholders; also files mixed shelf)
- EBS -1% (files for $250 mln mixed securities shelf offering)
Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- REAL +29%, VIAV +26.6%, LZ +24.7%, LASR +23.4%, PSIX +22.9%, SOUN +22.2%, OUST +20.6%, TRUP +20.1%, EXPE +16.5%, FROG +15.9%, ABCL +15.1%, ARLO +14.5%, CART +14%, NTRA +13.4%, JAMF +13.2%, EMBC +12.9%, ANIP +12.7%, NGVC +12.3%, GCT +12.2%, WLDN +12%, AORT +10.4%, ABL +10%, FIGS +9.6%, XYZ +8.7%, DOCS +8.5% (also acquires Pathway), PGNY +8.3%, MNST +8.1%, ARRY +7.9%, MP +7.7%, TXG +7.4% (also to acquire Scale Biosciences), ORGO +7.1%, DVAX +7%, TEM +7%, SYNA +6.3% (also authorizes new $150 mln share repurchase program), TTWO +6.3%, KRMN +5.8%, TRIP +5.7%, GILD +5.6%, AMPX +5.6%, AHR +5.5%, PLUS +5.3% (also initates dividend), ASTH +5.1%, WEST +5.1%, GSAT +4.7%, ZYME +4.4%, CMPO +4.4%, CLMT +4.3%, EGY +4.2%, IAS +4.1%, CGC +3.8%, WULF +3.6%, AKAM +3.3%, DH +3.3%, ALRM +3.2%, ATMU +3.1%, G +3%, POST +3% (also COO to retire), CRSR +2.8%, GMED +2.5%, TEAM +2.3%, ATGE +2.3%, CRNX +2.2%, AKRO +2%, INDI +1.8%, SOLV +1.8%, CYTK +1.8%, RKLB +1.7% (also successful completion of Systems Integration Review), WPM +1.7%, AMCX +1.5%, ONTO +1.4%, ACA +1.3%, DNN +1.3%, GEN +1.2%, MSI +1.1%, ED +1%, OTEX +1% (also increases dividend, announces $300 mln repurchase), AQN +1%
Other news:
- MRCC +9% (MRCC and HRZN to merge)
- OBIO +3.5% (announces the roll out of a protocol update, approved by the U.S. FDA, that significantly expands patient eligibility criteria for enrollment of the BACKBEAT study evaluating AVIM therapy in pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications)
- NXDR +2.7% (restructuring plan, CFO to retire)
- MDU +2.3% (files mixed securities shelf offering; also enters into $400 mln distribution agreement)
- HGTY +2.2% (prices secondary offering of 9.7 mln shares of common stock at $9.34 per share)
- LUMN +1.9% (CEO discloses purchase of 135,870 shares)
- ATYR +1.7% (files for $300 mln mixed securities shelf offering)
- OI +1.5% (insiders buying additional stock)
- AEE +1.1% (amends equity distribution sales agreement increasing aggregate gross sales price authorized by $1.25 bln)
- CXW +1% (judge orders construction of detention center be halted, according to AP)
- LITE +1% (announces capacity expansion of US facility)
- ARMK +1% (CEO disclosed the purchase of 6,387 shares)
- TFX +1% (discloses flurry of insider buys)
- BWIN +1% (CFO / Member of 10% owner group bought 10,000 shares)
- JCI +1% (entered into accelerated share repurchase transactions to repurchase $5.0 bln ordinary shares)
Early premarket gappers
-
Gapping up:
- REAL +31.9%, PSIX +29.3%, LZ +21.9%, SOUN +21.1%, TRUP +21%, LASR +20.7%, OUST +19.5%, EXPE +17.8%, FROG +17%, DVAX +16.5%, VIAV +16.4%, ABCL +14.9%, JAMF +14.6%, CART +14%, AORT +13.8%, NTRA +13.4%, GCT +13.3%, ARLO +12.6%, TEM +12.4%, NGVC +12.3%, FIGS +12.1%, WLDN +11.7%, MP +9.3%, XYZ +9.1%, KRMN +8.8%, DOCS +8.7%, ABL +8.5%, PGNY +8.4%, MNST +7.8%, MRCC +7.5%, ORGO +7.1%, SYNA +6.3%, LION +6.3%, AMPX +6.3%, CRNX +5.7%, GSAT +5.3%, TTWO +5.1%, ASTH +5.1%, WEST +5.1%, CTEV +5%, DNA +4.5%, ZYME +4.4%, PLUS +4.3%, EGY +4.2%, IAS +4.1%, CYTK +4.1%, OTEX +4.1%, TRIP +4%, ARRY +3.9%, GMED +3.7%, CRSR +3.6%, GILD +3.6%, DH +3.3%, BBDC +3.2%, AKAM +3.2%, ALRM +3.2%, TXG +3%, POST +3%, NXDR +2.7%, AHR +2.7%, VCTR +2.5%, ATGE +2.3%, MSI +2.2%, OMDA +2.1%, CMPO +2.1%, CARG +1.9%, TEAM +1.8%, EHTH +1.6%, LITE +1.6%, LUMN +1.6%, GLXY +1.4%, ACA +1.3%, ARMK +1.2%, HGTY +1.2%, AEE +1.1%, BWIN +1%
-
Gapping down:
- IOVA -30.7%, TTD -30.1%, SG -25.8%, VTEX -22.6%, SEZL -19.9%, XPOF -19.7%, HCAT -16.5%, TWLO -13.3%, AVDL -11.9%, PINS -11.3%, GRND -9.8%, TECX -9.6%, MCHP -8.5%, MTW -8.2%, BLND -7.6%, CTRI -7.3%, GT -7.1%, SERV -6.9%, AMN -6.6%, EVH -5.6%, RXT -5.5%, NRDS -5.1%, KBR -5%, CTMX -4.8%, GTN -4.6%, FNKO -4.4%, ACLX -4.4%, ESE -3.9%, FLUT -3.9%, GDDY -2.6%, DBX -2.6%, ETNB -2.2%, BTG -2.1%, YELP -2%, AGO -2%, LAMR -2%, AAOI -1.9%, RXST -1.9%, CPK -1.9%, WYNN -1.8%, ASND -1.8%, ICUI -1.5%, TXRH -1.4%, KTOS -1.2%, SMR -1.2%
>>> Up
* America Movil ADRs Raised to Neutral at JPMorgan; PT $21
* Athens Intnl Airport Raised to Buy at HSBC; PT 12.80 euros
* Diageo ADRs Raised to Neutral at Goldman; PT $107
* Diageo Raised to Neutral at Goldman; PT 2,000 pence
* Henkel Raised to Equal-Weight at Morgan Stanley; PT 72 euros
* Lassila & Tikanoja Raised to Buy at SEB Equities; PT 11.20 euros (+)
* Lotus Bakeries Raised to Buy at KBC Securities; PT 10,750 euros (+)
* MTELEKOM HB Raised to Outperform at Santander Biuro Maklerskie (+)
* Novartis ADRs Raised to Equal-Weight at Morgan Stanley; PT $123
* Novartis Raised to Equal-Weight at Morgan Stanley
* Novo Raised to Hold at Intron Health; PT 300 kroner (+)
* OTP Bank Raised to Buy at Citi; PT 33,500 forint
* Paradox Interactive Raised to Buy at SEB Equities; PT 195 kronor
* Peloton Raised to Buy at Goldman; PT $11.50
* Ralph Lauren PT Raised to $423 from $406 at JPMorgan
* Ralph Lauren PT Raised to $423 from $406 at JPMorgan
* Sanofi Raised to Overweight at JPMorgan; PT 105 euros
>>> Down
>>> Down
* Bankinter Cut to Hold at Deutsche Bank; PT 12.75 euros (+)
* Crocs Cut to Hold at Stifel; PT $85
* Crocs Cut to Equal-Weight at Barclays; PT $81
* CTP Cut to Hold at Jefferies; PT 20.30 euros
* Fraport Cut to Neutral at JPMorgan; PT 73 euros
* Honda ADRs Cut to Hold at CFRA
* Honda ADRs Cut to Hold at CFRA
* Just Group Cut to Equal-Weight at Barclays; PT 220 pence
* Multiconsult Cut to Sell at SEB Equities; PT 205 kroner
* Roche Cut to Underweight at Morgan Stanley; PT 245 Swiss francs
* Roche ADRs Cut to Underweight at Morgan Stanley; PT $39
* Sandoz Group Cut to Hold at Jefferies; PT 47.60 Swiss francs
* Soitec Cut to Neutral at BNPP Exane; PT 36 euros
>>> Initiation
>>> Initiation
* Egetis Therapeutics AB Rated New Buy at Van Lanschot Kempen (+)
* Rheinmetall ADRs Rated New Outperform at BNPP Exane; PT $532
* Swissquote Rated New Neutral at Oddo BHF; PT 555 Swiss francs
* Swissquote Rated New Neutral at Oddo BHF; PT 555 Swiss francs
* Tesla Reinstated Overweight at Morgan Stanley; PT $410
>>> Call
* Mastercard, Visa Not Threatened by Fee Ruling: Jefferies
>>> Call
* Mastercard, Visa Not Threatened by Fee Ruling: Jefferies